Harmony Biosciences Holdings, Inc.

Ownership Transactions Reported by 16 Insiders

Symbol
HRMY on Nasdaq
Location
630 W Germantown Pike, Suite 215, Plymouth Meeting, Pennsylvania

Insiders trading volume in the past year

Harmony Biosciences Holdings, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Andreas Wicki Director $71.7M Dec 12, 2022
Kumar Budur Chief Medical Officer $2.55M May 1, 2024
Jeffrey M. Dayno PRESIDENT, CEO, Director $1.4M Jan 24, 2024
Sandip Kapadia Chief Financial Officer $715K Mar 29, 2024
Jeffrey Dierks Chief Commercial Officer $359K -$390K -52.1% Mar 15, 2024
Andrew Serafin Chief Strategy Officer $334K Jan 24, 2024
Linda M. Szyper Director May 29, 2024
Peter Anastasiou Director May 29, 2024
Gary Sender Director May 29, 2024
Eric Motley Director May 20, 2021
R. Mark Graf Director May 29, 2024
Jack Nielsen Director May 29, 2024
John C. Jacobs PRESIDENT, CEO, Director Aug 15, 2022
Antonio J. Gracias Director May 29, 2024
Jeffrey S. Aronin Director Mar 24, 2022
Juan A. Sabater Director May 29, 2024

Recent Insider Transactions by Companies or Individuals for Harmony Biosciences Holdings, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.